Billionaire Bruce Kovner buys another 950K shares in Synta

In the past month, stock in Synta Pharmaceuticals Corp. (Nasdaq: SNTA) has fallen 35 percent after a presentation of its lead drug aimed at lung cancer...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.